Found: 32
Select item for more details and to access through your institution.
HDAC3 overexpression is an independent predictor of poor prognosis and is associated with genomic instability in prostate cancer.
- Published in:
- Canadian Journal of Pathology, 2016, v. 8, p. 14
- By:
- Publication type:
- Article
High BCAR1 expression is linked to adverse tumour features and early PSA recurrence in ERG negative prostate cancers.
- Published in:
- Canadian Journal of Pathology, 2016, v. 8, p. 14
- By:
- Publication type:
- Article
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 286, doi. 10.3390/ijms18020286
- By:
- Publication type:
- Article
VEGFR-1 Overexpression Identifies a Small Subgroup of Aggressive Prostate Cancers in Patients Treated by Prostatectomy.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 4, p. 8591, doi. 10.3390/ijms16048591
- By:
- Publication type:
- Article
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer.
- Published in:
- Microarrays (2076-3905), 2014, v. 3, n. 2, p. 137, doi. 10.3390/microarrays3020137
- By:
- Publication type:
- Article
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
5q21 deletion is often heterogeneous in prostate cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2019, v. 58, n. 8, p. 509, doi. 10.1002/gcc.22730
- By:
- Publication type:
- Article
Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer.
- Published in:
- Scientific Reports, 2017, v. 7, n. 1, p. 1, doi. 10.1038/s41598-017-02279-x
- By:
- Publication type:
- Article
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0134614
- By:
- Publication type:
- Article
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128525
- By:
- Publication type:
- Article
Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A non-diploid DNA status is linked to poor prognosis in renal cell cancer.
- Published in:
- World Journal of Urology, 2021, v. 39, n. 3, p. 829, doi. 10.1007/s00345-020-03226-8
- By:
- Publication type:
- Article
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancer.
- Published in:
- World Journal of Urology, 2018, v. 36, n. 6, p. 877, doi. 10.1007/s00345-018-2225-7
- By:
- Publication type:
- Article
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions.
- Published in:
- Pathology & Oncology Research, 2020, v. 26, n. 4, p. 2709, doi. 10.1007/s12253-020-00861-9
- By:
- Publication type:
- Article
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy.
- Published in:
- Carcinogenesis, 2017, v. 38, n. 12, p. 1180, doi. 10.1093/carcin/bgx105
- By:
- Publication type:
- Article
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.
- Published in:
- Carcinogenesis, 2017, v. 38, n. 1, p. 19, doi. 10.1093/carcin/bgw116
- By:
- Publication type:
- Article
Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters.
- Published in:
- Carcinogenesis, 2015, v. 36, n. 11, p. 1333, doi. 10.1093/carcin/bgv137
- By:
- Publication type:
- Article
High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.
- Published in:
- Prostate, 2017, v. 77, n. 15, p. 1528, doi. 10.1002/pros.23431
- By:
- Publication type:
- Article
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer.
- Published in:
- Prostate, 2016, v. 76, n. 3, p. 259, doi. 10.1002/pros.23120
- By:
- Publication type:
- Article
High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer.
- Published in:
- Prostate, 2011, v. 71, n. 3, p. 281, doi. 10.1002/pros.21241
- By:
- Publication type:
- Article
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion‐positive prostate cancers.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 2, p. 575, doi. 10.1002/ijc.32957
- By:
- Publication type:
- Article
Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 5, p. 1199, doi. 10.1002/ijc.29860
- By:
- Publication type:
- Article
Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors.
- Published in:
- Journal of Pathology: Clinical Research, 2021, v. 7, n. 6, p. 577, doi. 10.1002/cjp2.237
- By:
- Publication type:
- Article
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases.
- Published in:
- Oncology Letters, 2018, v. 16, n. 5, p. 6238, doi. 10.3892/ol.2018.9417
- By:
- Publication type:
- Article
Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder.
- Published in:
- Disease Markers, 2019, p. 1, doi. 10.1155/2019/2532518
- By:
- Publication type:
- Article
Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-30975-9
- By:
- Publication type:
- Article
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1555-8
- By:
- Publication type:
- Article
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 538, doi. 10.1186/s12885-015-1555-8
- By:
- Publication type:
- Article
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion.
- Published in:
- Oncology Reports, 2015, v. 34, n. 3, p. 1211, doi. 10.3892/or.2015.4080
- By:
- Publication type:
- Article